Clear hydro-gel, compared to ointment, provides improved eye comfort after brief surgery.
OBJECTIVE
Anesthesia impairs lid closure and decreases tear secretion and stability. Protection may, in principle, be conveyed by manual eye closure, taping the eyelids closed, and by instillation of protective substances into the conjunctival sac. Both hydro-gels and ointments are used in clinical practice. It was the objective of the present study to compare a transparent clear ocular hydro-gel (Vidisic) and a commonly used dexpanthenol and vitamin A (Oleovit) based ointment as examples of these classes of ocular lubricants in their capability to provide perioperative eye comfort. Furthermore, their bacteriostatic properties were assessed in vitro.


METHODS
Ninety-two consecutive patients undergoing total iv general anesthesia were randomly allocated to receive either ocular dexpanthenol ointment or a clear hydro-gel after induction of anesthesia. Subjects were assessed one hour following termination of anesthesia.


RESULTS
Main findings were an increased incidence of foreign body sensation, adherent eyelashes and disturbance elicited by blurred vision in the ointment group as compared to clear hydro-gel (P < 0.001). Bacterial growth was significantly attenuated by the ocular hydro-gel as compared to ointment.


CONCLUSIONS
Clear ocular hydro-gel offers improved patient comfort and decreased ocular inflammation as compared to conventional eye ointments. In addition, it decreases bacterial growth. Therefore, the use of clear ocular hydro-gel for perioperative ocular comfort is suggested.
Smolle
Michaela
M
Department of Anesthesiology and Critical Care Medicine, University of Innsbruck, Innsbruck, Austria.
Keller
Christian
C
Pinggera
Germar
G
Deibl
Martina
M
Rieder
Josef
J
Lirk
Philipp
P
D000179:Acrylates / Q000627:therapeutic use*; D000768:Anesthesia, General / Q000009:adverse effects*; D016009:Chi-Square Distribution; D015169:Colony Count, Microbial; D005123:Eye / Q000187:drug effects* / Q000503:physiopathology; D005260:Female; D006801:Humans; D020100:Hydrogels / Q000627:therapeutic use; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D019635:Neurosurgical Procedures / Q000009:adverse effects; D009824:Ointments; D010205:Pantothenic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects; D013997:Time Factors; D013520:Urologic Surgical Procedures / Q000009:adverse effects; D014801:Vitamin A / Q000627:therapeutic use*; D014985:Xerophthalmia / Q000517:prevention & control*
D000179:Acrylates; D020100:Hydrogels; D009824:Ointments; D014801:Vitamin A; C049065:vidisic; D010205:Pantothenic Acid; C007288:dexpanthenol